首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Mannose‐6‐Phosphate Receptor: A Target for Theranostics of Prostate Cancer
Authors:Dr Ophélie Vaillant  Dr Khaled El Cheikh  Dr David Warther  Dr David Brevet  Dr Marie Maynadier  Dr Elise Bouffard  Dr Frédéric Salgues  Dr Audrey Jeanjean  Dr Pierre Puche  Dr Catherine Mazerolles  Dr Philippe Maillard  Dr Olivier Mongin  Dr Mireille Blanchard‐Desce  Dr Laurence Raehm  Dr Xavier Rébillard  Dr Jean‐Olivier Durand  Dr Magali Gary‐Bobo  Dr Alain Morère  Dr Marcel Garcia
Institution:1. Institut des Biomolécules Max Mousseron, UMR 5247 CNRS, UM 1, UM 2‐Faculté de Pharmacie, 15 Avenue Charles Flahault, 34093 Montpellier cedex 05 (France);2. Institut Charles Gerhardt Montpellier, UMR‐5253 CNRS‐UM2‐ENSCM‐UM1 cc 1701, Place Eugène Bataillon, F‐34095 Montpellier cedex 05. (France);3. NanoMedSyn, Faculté de Pharmacie, Montpellier cedex 05 (France);4. Institut chirurgie viscérale, Clinique mutualiste Beau‐Soleil, 119 avenue de Lodève, 34070 Montpellier (France);5. Service d'Anatomie pathologique et Histologie‐Cytologie, P?le Biologie, H?pital de Rangueil, Toulouse cedex 9 (France);6. Institut Curie, CNRS UMR 176, Orsay (France);7. Institut Des Sciences Chimiques de Rennes, CNRS UMR 6226 Université Rennes 1, Campus Beaulieu, Rennes Cedex (France);8. Univ. Bordeaux, Institut des Sciences Moléculaires, UMR CNRS 5255, Talence Cedex (France);9. Service d'urologie, Clinique mutualiste Beau‐Soleil, Montpellier (France)
Abstract:The development of personalized and non‐invasive cancer therapies based on new targets combined with nanodevices is a major challenge in nanomedicine. In this work, the over‐expression of a membrane lectin, the cation‐independent mannose 6‐phosphate receptor (M6PR), was specifically demonstrated in prostate cancer cell lines and tissues. To efficiently target this lectin a mannose‐6‐phosphate analogue was synthesized in six steps and grafted onto the surface of functionalized mesoporous silica nanoparticles (MSNs). These MSNs were used for in vitro and ex vivo photodynamic therapy to treat prostate cancer cell lines and primary cell cultures prepared from patient biopsies. The results demonstrated the efficiency of M6PR targeting for prostate cancer theranostic.
Keywords:cancer  carbohydrates  nanoparticles  receptors  synthesis design
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号